Loading…
Amarin Corporation plc is projected to rise to $17.21 by 2027, a +21% move from its current price of $14.26. AMRN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $14.07 | $14.27 | $14.47 | +0.06% |
| Aug 4 | $13.99 | $14.28 | $14.57 | +0.13% |
| Aug 5 | $13.94 | $14.29 | $14.65 | +0.19% |
| Aug 6 | $13.89 | $14.30 | $14.71 | +0.25% |
| Aug 7 | $13.85 | $14.30 | $14.77 | +0.31% |
| Aug 8 | $13.82 | $14.31 | $14.82 | +0.38% |
| Aug 9 | $13.79 | $14.32 | $14.87 | +0.44% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $13.79 | $14.32 | $14.87 | +0.44% |
| Week 2 | $13.64 | $14.39 | $15.18 | +0.88% |
| Week 3 | $13.53 | $14.45 | $15.43 | +1.32% |
| Week 4 | $13.45 | $14.51 | $15.65 | +1.77% |
| Week 5 | $13.39 | $14.58 | $15.86 | +2.21% |
| Week 6 | $13.34 | $14.64 | $16.06 | +2.66% |
| Week 7 | $13.30 | $14.70 | $16.25 | +3.11% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Amarin Corporation plc is a pharmaceutical company engaged in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia.
The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa.
The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Amarin Corporation plc, ticker AMRN, is a healthcare stock currently trading at $14.46 per share, with a market cap of $303.21M, and a rank of 3503. The current price sits within a forecasted trajectory, reflecting a 2026 average price of $14.46 with a 2026 min of $13.50 and a max of $19.86, and a neutral sentiment for that year.
From 2027 onward, the forecast envisions a bullish path, with 2027 average $17.58, 2028 $20.03, 2029 $21.46, and 2030 $21.33, along with rising ROI figures (21.6% in 2027, 38.5% in 2028, 48.4% in 2029, and 47.5% in 2030).
Looking further out, the forecast implies substantial upside: 2040 average price $58.49 with a 304.5% ROI and 2050 average price $107.45 with a 643.1% ROI, all within a bullish sentiment framework.
A major floor 17.0% below — a decisive break under it would weaken the trend.
The nearest floor, 5.0% below — buyers have tended to step in here.
The nearest ceiling, 15.5% above — a clean break opens room to run.
A major ceiling 24.0% above — clearing it would confirm fresh momentum.
Key AMRN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AMRN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $14.08 | Buy | $14.11 | Buy |
| MA 10 | $13.88 | Buy | $14.10 | Buy |
| MA 20 | $14.34 | Sell | $14.34 | Sell |
| MA 50 | $14.81 | Sell | $14.65 | Sell |
| MA 100 | $14.76 | Sell | $14.77 | Sell |
| MA 200 | $15.19 | Sell | $14.78 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.06 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | -10.39 | Neutral |
| Williams %R (14) | -21.98 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | -1.38 | Sell |
| Bollinger %B (20,2) | 0.47 | Neutral |
| Stochastic %K (14) | 78.02 | Neutral |
| TRIX (15) | -0.34 | Sell |
| Awesome (5,34) | -0.90 | Sell |
| Ultimate (7,14,28) | 63.93 | Neutral |
| Momentum (10) | 0.32 | Buy |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 14.31 | Sell |
| ADX (14) | 21.87 | Sell |
| ATR (14) | 0.20 | Info |
The 30-day picture shows a range from $12.98 to $16.11. The RSI14 is 40, indicating bearish momentum.
The price is trading below the 50-day simple moving average of $14.99 and the 200-day simple moving average of $15.43, suggesting near-term softness. Support is seen at $13.80 and resistance at $16.47.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $13.50 | $14.26 | $19.34 | 0% | Neutral | |
| $14.12 | $17.21 | $21.93 | +21% | Bullish | |
| $15.47 | $19.23 | $25.17 | +35% | Bullish | |
| $16.42 | $20.72 | $27.71 | +45% | Bullish | |
| $16.18 | $20.70 | $28.19 | +45% | Bullish | |
| $17.88 | $23.15 | $32.03 | +62% | Bullish | |
| $20.49 | $26.84 | $37.66 | +88% | Bullish | |
| $23.27 | $30.79 | $43.77 | +116% | Bullish | |
| $25.34 | $33.88 | $48.73 | +138% | Bullish | |
| $26.37 | $35.58 | $51.76 | +150% | Bullish | |
| $37.57 | $52.88 | $80.63 | +271% | Bullish | |
| $65.39 | $98.71 | $161.35 | +592% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $13.50 | $14.26 | $17.65 | +0.00% |
| September 2026 | $12.98 | $15.22 | $18.24 | +6.71% |
| October 2026 | $12.82 | $15.10 | $18.23 | -0.79% |
| November 2026 | $12.94 | $15.30 | $18.59 | +1.32% |
| December 2026 | $13.34 | $15.83 | $19.34 | +3.46% |
Click any year to see its month-by-month AMRN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect AMRN to range from $13.50 to $19.34 through 2026. The $14.26 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The AMRN price prediction for 2027 points to an average of $17.21 (low $14.12, high $21.93) — a potential gain of +21% on today's $14.26. Momentum favours further upside here.
In 2028, AMRN is projected to trade between $15.47 and $25.17, averaging $19.23 — a potential gain of +35% from today's $14.26. That is up +12% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Amarin Corporation plc's 2029 outlook centres on $20.72, within a $16.42 to $27.71 range. That is up +8% on the projected 2028 average. That marks a +45% change versus current levels. Momentum favours further upside here.
By 2030, AMRN could reach as high as $28.19, with a base case around $20.70 and support toward $16.18 — roughly +45% from $14.26. Buyers look set to stay in control over this stretch.
Expect AMRN to range from $17.88 to $32.03 through 2031. The $23.15 average target implies a +62% move from current prices. That is up +12% on the projected 2030 average. Momentum favours further upside here.
The AMRN price prediction for 2032 points to an average of $26.84 (low $20.49, high $37.66) — a potential gain of +88% on today's $14.26. Buyers look set to stay in control over this stretch.
In 2033, AMRN is projected to trade between $23.27 and $43.77, averaging $30.79 — a potential gain of +116% from today's $14.26. That is up +15% on the projected 2032 average. Momentum favours further upside here.
Amarin Corporation plc's 2034 outlook centres on $33.88, within a $25.34 to $48.73 range. That is up +10% on the projected 2033 average. That marks a +138% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, AMRN could reach as high as $51.76, with a base case around $35.58 and support toward $26.37 — roughly +150% from $14.26. Momentum favours further upside here.
Expect AMRN to range from $37.57 to $80.63 through 2040. The $52.88 average target implies a +271% move from current prices. That is up +49% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The AMRN price prediction for 2050 points to an average of $98.71 (low $65.39, high $161.35) — a potential gain of +592% on today's $14.26. Momentum favours further upside here.
Investing $1,000 in AMRN today (≈ 70.126227 AMRN) could be worth
$6,922.33
+$5,922.33 (+592%) by 2050 · US Dollar
Based on the average projected AMRN price of $98.71 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AMRNwould be worth at today's price.
$1,000 invested in AMRN on Jul 31, 2025 (≈ 68.870521 AMRN) would be worth
$982.09
-$17.91 (-1.8%) today · 0.98× · US Dollar
Based on a AMRN entry price of $14.52 vs. today's $14.26.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $13.55 | $1,052.4 | +5.2% |
| 1 month ago | $16.47 | $865.82 | -13.4% |
| 3 months ago | $14.07 | $1,013.5 | +1.4% |
| 6 months ago | $15 | $950.67 | -4.9% |
| 1 year ago | $14.52 | $982.09 | -1.8% |
| All time (5.0y) ago | $86 | $165.81 | -83.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AMRN forecast.
Our base-case forecast reaches $29.00 around 2033.
Implied market cap at $29.00: $608.1M
In the near multi-year horizon, the forecast begins with a 2026 average of $14.46, a 0% ROI, and a Neutral sentiment.
From 2027 through 2030, the path remains bullish, with 2027 average $17.58 (21.6% ROI), 2028 $20.03 (38.5%), 2029 $21.46 (48.4%), and 2030 $21.33 (47.5%).
The uptrend continues into 2031-2035, where the average prices are $24.83, $28.66, $32.29, $36.57, and $38.13 with ROIs of 71.7%, 98.2%, 123.3%, 152.9%, and 163.7% respectively, all bullish.
By 2040 the forecast calls for an average of $58.49 (304.5% ROI) and by 2050 an average of $107.45 (643.1% ROI), with ongoing bullish sentiment. These figures are estimates, not guarantees, and actual results may differ.
Tap a question to reveal the answer.
2030 average price: $21.33; min: $16.66; max: $29.07; ROI: 47.5%; sentiment: BULLISH.
The forecast shows a bullish trajectory from 2027 onward, with 2027 average $17.58 (ROI 21.6%), 2028 $20.03 (38.5%), 2029 $21.46 (48.4%), 2030 $21.33 (47.5%), and a long-run upside to 2050 average $107.45 with ROI 643.1%.
Yes—the 2050 forecast lists an average price of $107.45 and a max of $175.67, indicating potential to surpass $100 in the long term.
RSI14 is 40. The 30-day range is $12.98 to $16.11. The stock is below the 50-day SMA ($14.99) and the 200-day SMA ($15.43). Support is at $13.80 and resistance at $16.47.
Current price: $14.46. Market cap: $303.21M.
Amarin Corporation plc Community Discussion
0Share your Amarin Corporation plc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.